NasdaqHealth CareHealth Care ServicesS&P SmallCap 600
$7.34
-0.22 (-2.91%)
Close of Nov 06, 2026 · end-of-day data
ALHC 8-K filings in 2025
Every material Form 8-K Alignment Healthcare filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Alignment Healthcare reported third-quarter 2025 revenue of $993.7 million, up 43.5% year over year, and net income of $3.7 million, compared with a net loss of $26.4 million a year earlier. The company raised its full-year 2025 outlook for membership, revenue, adjusted gross profit and adjusted EBITDA, which points to stronger expected results for shareholders, though its fourth-quarter adjusted EBITDA is guided to a loss.
Q3 2025 revenue was $993.7 million, up 43.5% year over year; health plan membership was about 229,600, up 25.9%.
Q3 2025 net income was $3.7 million, versus a net loss of $26.4 million in Q3 2024; adjusted EBITDA was $32.4 million, versus $5.9 million.
Full-year 2025 revenue guidance is $3,931 million to $3,946 million, and full-year adjusted EBITDA guidance is $90 million to $98 million.
Fourth-quarter 2025 adjusted EBITDA is guided to a loss of $9 million to $1 million.
Alignment Healthcare reported second-quarter 2025 revenue of $1,015.3 million, up 49.0% year over year, and net income of $15.7 million, compared with a net loss of $24.0 million a year earlier. The company raised its full-year 2025 outlook for membership, revenue, adjusted gross profit and adjusted EBITDA.
Q2 2025 total revenue was $1,015.3 million, up 49.0% from the prior-year quarter; net income was $15.7 million versus a $24.0 million loss in Q2 2024.
Adjusted EBITDA was $45.9 million in Q2 2025, compared with $6.0 million a year earlier; adjusted gross profit was $135.2 million.
Full-year 2025 revenue outlook is $3,885 million to $3,910 million, and adjusted EBITDA outlook is $69 million to $83 million.
Third-quarter 2025 revenue outlook is $970 million to $985 million, with health plan membership of 225,000 to 227,000 at September 30, 2025.
Alignment Healthcare reported first-quarter 2025 revenue of $926.9 million, up 47.5% year over year, and a net loss of $9.4 million, narrowed from $46.6 million a year earlier. The company raised the midpoints of its 2025 outlook for membership, revenue, adjusted gross profit and adjusted EBITDA, and said CFO Thomas Freeman will be succeeded by Jim Head effective May 2, 2025.
Q1 2025 revenue was $926.9 million, up 47.5%; net loss was $9.4 million versus $46.6 million in Q1 2024.
Adjusted EBITDA was $20.2 million, compared with a loss of $12.0 million in Q1 2024.
Health plan membership was about 217,500 at March 31, 2025, up 31.7% year over year.
Twelve-month 2025 revenue outlook is $3,770 million to $3,815 million; Jim Head succeeds Thomas Freeman as CFO effective May 2, 2025.
Alignment Healthcare said its Chief Experience Officer, Hakan Kardes, resigned to pursue other professional opportunities. The resignation took effect immediately, but he will stay employed through May 16, 2025 to help transfer his duties to other senior employees.
Hakan Kardes notified the company of his resignation on April 9, 2025.
Resignation as Chief Experience Officer was effective immediately.
Kardes remains employed through May 16, 2025 to facilitate the transition of duties.
Alignment Healthcare reported fourth-quarter and full-year 2024 results on February 27, 2025, with revenue growth of 50.7% in the quarter and 48.3% for the year. Net losses narrowed from the prior year, and the company issued 2025 guidance of $3.72 billion to $3.78 billion in revenue and $35 million to $60 million in adjusted EBITDA.
Q4 2024 total revenue was $701.2 million, up 50.7% year over year; net loss was $(31.1) million versus $(47.2) million a year earlier.
Full-year 2024 total revenue was $2,703.6 million, up 48.3%; net loss was $(128.1) million versus $(148.2) million in 2023.
2025 guidance: revenue of $3.72 billion to $3.78 billion and adjusted EBITDA of $35 million to $60 million.
Health plan membership was about 189,100 at December 31, 2024, up 58.6% year over year.
Alignment Healthcare said it had about 209,900 health plan members as of January 1, 2025, up about 35% year over year, and expects 225,000 to 231,000 members by December 31, 2025. It reaffirmed its 2024 guidance and its confidence in about $40 million of adjusted EBITDA in 2025, with 2025 guidance to come on its fourth-quarter earnings call. The filing also says Dawn Maroney was promoted to President, effective immediately, to oversee day-to-day operations, while the filing provides no fourth-quarter or full-year 2024 results.
Health plan membership of about 209,900 as of January 1, 2025, up about 35% from January 1, 2024
Expects 225,000 to 231,000 members as of December 31, 2025, about 22% to 25% growth versus the midpoint of year-end 2024 membership guidance
Reaffirmed 2024 guidance: revenue of $2,665 million to $2,680 million and adjusted EBITDA of ($10) million to $5 million
Dawn Maroney promoted to President effective January 13, 2025; she reports to founder and CEO John Kao
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Alignment Healthcare filing is on SEC EDGAR ↗. 8-K briefs of other companies →